Overview
Safeguard’s ability to provide both growth capital and strategic and operational guidance translates into significant competitive advantages for our partner companies. Our management team includes C-level executives who have been in the entrepreneur’s seat before and understand the challenges companies face at this stage.
In addition, our life sciences and technology advisory board provide expert guidance, strategic direction and access to numerous networking and business relationships, benefiting Safeguard and its partner companies. These capabilities help us attract the next generation innovative entrepreneurs.
Safeguard has proven that building market-leading, great companies demands a clear operational focus and a patient capital approach. The continued success of our partner companies proves that Safeguard's vision is being realized.
In life sciences, Safeguard targets high-value areas of Molecular and Point-of-Care Diagnostics, Medical Devices, Regenerative Medicine, Specialty Pharmaceuticals and selected healthcare services, which represent lower regulatory risk and near-term revenue. Our current partner companies include:
In technology, Safeguard targets recurring revenue companies in Internet / New Media, Financial Services IT, Healthcare IT and selected business services, which share a “transaction enabling” thesis and are near cash-flow position. Our current partner companies include:
